Erratum: Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study (Lancet (2014) 383 (622-629))

GoodareH.; VaidyaJ.S.; KrumH.; MillingtonJ.; WenzF.; SchlaichM.P.; B?hmM.; PondP.; BulsaraM.; RogersC.; BainbridgeD.

首页> 外文期刊>The Lancet >Erratum: Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study (Lancet (2014) 383 (622-629))

【24h】

Erratum: Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study (Lancet (2014) 383 (622-629))

机译：误诊：治疗高血压患者的经皮肾去神经症：对称HTN-1研究的最后3年报告（柳叶刀（2014）383（622-629））

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Krum H, Schlakh MP, Bohm M, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 2014; 383:622-29-in this Article (published online Nov 7,2013), Paul Sobotka should have been listed as an author. This correction has been made to the online version as of Feb 14, 2014, and to the printed Article.

机译：Krum H，Schlakh MP，Bohm M等。治疗抗性高血压患者的经皮肾病：对称HTN-1研究的最后3年报告。兰蔻2014; 383：622-29-本文（11月7,2013在线发布），保罗Sobotka应该被列为作者。截至2014年2月14日和印刷文章的在线版本已进行此校正。

著录项

来源
《The Lancet》 |2014年第9917期|共1页
作者
GoodareH.; VaidyaJ.S.; KrumH.; MillingtonJ.; WenzF.; SchlaichM.P.; B?hmM.; PondP.; BulsaraM.; RogersC.; BainbridgeD.;
展开▼
作者单位

RAGE (Radiotherapy Action Group Exposure) Southborough-TN4 0NX United Kingdom;

RAGE (Radiotherapy Action Group Exposure) Southborough-TN4 0NX United Kingdom;

Northwestern University Feinberg School of Medicine Chicago 60611 IL United States;

RAGE (Radiotherapy Action Group Exposure) Southborough-TN4 0NX United Kingdom;

RAGE (Radiotherapy Action Group Exposure) Southborough-TN4 0NX United Kingdom;

Northwestern University Feinberg School of Medicine Chicago 60611 IL United States;

Northwestern University Feinberg School of Medicine Chicago 60611 IL United States;

RAGE (Radiotherapy Action Group Exposure) Southborough-TN4 0NX United Kingdom;

RAGE (Radiotherapy Action Group Exposure) Southborough-TN4 0NX United Kingdom;

RAGE (Radiotherapy Action Group Exposure) Southborough-TN4 0NX United Kingdom;

RAGE (Radiotherapy Action Group Exposure) Southborough-TN4 0NX United Kingdom;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献

1. Erratum: Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study (Lancet (2014) 383 (622-629)) [J] . GoodareH., VaidyaJ.S., KrumH., The Lancet . 2014,第9917期

机译：误诊：治疗高血压患者的经皮肾去神经症：对称HTN-1研究的最后3年报告（柳叶刀（2014）383（622-629））
2. Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study [J] . KrumH., SchlaichM.P., SobotkaP.A., The Lancet . 2014,第9917期

机译：治疗抗性高血压患者的经皮肾去丧失：关于合作社的最后3年的3年报告HTN-1研究
3. Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study [J] . KrumH., SchlaichM.P., SobotkaP.A., The Lancet . 2014,第9917期

机译：难治性高血压患者的经皮肾神经支配：Symplicity HTN-1研究的最后3年报告
4. Editors choice: Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial [O] . Murray D. Esler, Michael Böhm, Horst Sievert, -1

机译：编辑选择：基于导管的肾脏去神经治疗对难治性高血压患者的治疗：SYMPLICITY HTN-2随机临床试验的结果为36个月
5. Renal denervation for resistant hypertension: the Symplicity HTN-1 study [O] . Wang, Yutang 2014

机译：肾脏去神经治疗抵抗性高血压：Symplicity HTN-1研究

Erratum: Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-1 study (Lancet (2014) 383 (622-629))

摘要

著录项

相似文献

相关主题

期刊订阅